A375 |
Malignant melanoma skin cancer |
C. annuum L. |
Capsicum annuum Linnaeus |
CAP |
Capsaicin |
DDs |
Drug Delivery Systems |
DLS |
Dynamic Light Scattering |
DMSO |
Dimethyl Sulfoxide |
DPPC |
1,2-Dipalmitoyl-sn-glycero-3-phosphocholine |
DSC |
Differential Scanning Calorimetry |
DSPE-PEG2000 |
1, 2-Distearoyl-sn-glycero-3-phosphoethanolamine-NPEG2000 |
EE |
Encapsulation Efficiency |
EGFR |
Epidermal growth factor receptor |
EMEM |
Eagle’s Minimum Essential Medium |
FBS |
Fetal bovine serum |
FDA |
Food and Drug Administration |
HPLC |
High performance liquid chromatography |
H0 |
Null hypothesis |
Ha |
Null hypothesis |
IC50
|
Half maximal inhibitory concentration |
k562 |
Myelogenous leukemia cancer cell line |
LLOD |
Lower limit of Detection |
LLOQ |
Lower limit of Quantitation |
MCF-7 |
Breast cancer cell line, Michigan Cancer Foundation-7 |
MDA-MB-231 |
Triple-negative breast cancer (TNBC) |
MEM |
Minimum Essential Medium |
MTT |
3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyltetrazolium Bromide solution |
NP |
Nanoparticles |
PBS |
Phosphate Buffered Saline |
PANC1 |
Pancreas cancer |
PDI |
Polydispersity Index |
RPMI |
RPMI 1640 growth medium |
TEM |
Transmission Electron Microscopy |
TRPV1 |
The transient receptor potential cation channel subfamily V member 1 |
Z |
Zeta |